MoneyWorks4Me

Lupin informs about transcript of conference call

25 May 2022 Evaluate

Pursuant to Regulation 30(2) read with Schedule Ill Part A Para A (15) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Transcript of the Q4 FY2022 Investor Meet/ Earnings Conference Call held on Thursday, May 19, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..